2021 Nelson's Pediatric Antimicrobial Therapy

2021 Nelson's Pediatric Antimicrobial Therapy

  • Auteur: Bradley , John S.; Nelson , John D.; Barnett, Elizabeth; Cantey, MD, Joseph B.; Kimberlin, David W.; Palumbo, Paul E; Sauberan, Jason; Smart, J. Howard; Steinbach, William J
  • Éditeur: American Academy of Pediatrics
  • ISBN: 9781610024440
  • eISBN Pdf: 9781610024457
  • Lieu de publication:  Illinois , United States
  • Année de publication électronique: 2021
  • Mois : Janvier
  • Pages: 362
  • Langue: Anglais
Completely updated and revised, the 27th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children, including COVID-19. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices.

Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.

New in the 27th edition:
  • Continuous updates of drug and dosing changes available online at aap.org/Nelsons
  • 4 new chapters
  • Reorganized chapter order to improve functionality
  • Introduction
  • Ch 1. Antimicrobial Therapy According to Clinical Syndromes
    • A. Skin and Soft Tissue Infections
    • B. Skeletal Infections
    • C. Eye Infections
    • D. Ear and Sinus Infections
    • E. Oropharyngeal Infections
    • F. Lower Respiratory Tract Infections
    • G. Cardiovascular Infections
    • H. Gastrointestinal Infections
    • I. Genital and Sexually Transmitted Infections
    • J. Central Nervous System Infections
    • K. Urinary Tract Infections
    • L. Miscellaneous Systemic Infections
  • Ch 2. Antimicrobial Therapy for Neonates
    • A. Recommended Therapy for Selected Neonatal Conditions
    • B. Antimicrobial Dosages for Neonates
    • C. Aminoglycosides
    • D. Vancomycin
    • E. Use of Antimicrobials During Pregnancy or Breastfeeding
  • Ch 3. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
    • A. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)
    • B. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)
    • C. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)
    • D. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
  • Ch 4. Choosing Among Antibiotics Within a Class: Beta-lactams and Beta-lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones
  • Ch 5. Preferred Therapy for Specific Fungal Pathogens
    • A. Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal Susceptibilities
    • B. Systemic Infections
    • C. Localized Mucocutaneous Infections
  • Ch 6. Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins
  • Ch 7. Preferred Therapy for Specific Viral Pathogens
    • A. Overview of Non-HIV, Non-Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
    • B. Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
    • C. Preferred Therapy for Specific Viral Pathogens
  • Ch 8. Choosing Among Antiviral Agents
  • Ch 9. Preferred Therapy for Specific Parasitic Pathogens
    • A. Selected Common Pathogenic Parasites and Suggested Agents for Treatment
    • B. Preferred Therapy for Specific Parasitic Pathogens
  • Ch 10. Choosing Among Antiparasitic Agents: Antimalarial Drugs, Nitroimidazoles, Benzimidazoles, and Neglected Tropical Diseases
  • Ch 11. How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatment Outcomes
  • Ch 12. Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and Methicillin-Resistant Staphylococcus aureus
  • Ch 13. Antibiotic Therapy for Children Who Are Obese
  • Ch 14. Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections
  • Ch 15. Antimicrobial Prophylaxis/Prevention of Symptomatic Infection
    • A. Postexposure Antimicrobial Prophylaxis to Prevent Infection
    • B. Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection
    • C. Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection
    • D. Surgical/Procedure Prophylaxis
  • Ch 16. Approach to Antibiotic Allergies
  • Ch 17. Antibiotic Stewardship
  • Ch 18. Alphabetic Listing of Antimicrobials
    • A. Systemic Antimicrobials With Dosage Forms and Usual Dosages
    • B. Topical Antimicrobials (Skin, Eye, Ear, Mucosa)
  • Appendix: Nomogram for Determining Body Surface Area
  • References
  • Index

SUBSCRIBE TO OUR NEWSLETTER

By subscribing, you accept our Privacy Policy